<正>1文献来源Nanda R,Chow LQ,Dees EC,et al.Pembroli-zumab in patients with advanced triple-negative breastcancer:PhaseⅠ......

3背景派姆单抗(Pembrolizumab)是一种高亲和力和高选择性的抗PD-1单克隆IgG4-k抗体,派姆单抗已被证实在其他肿瘤抗PD-1治疗中具有......

3背景三阴性乳腺癌（triple negative breast cancer，TNBC）即激素受体（hormone receptor，HR）阴性、人表皮生长因子受体2（humanepid ermal r......